SCHEMBL30569129

SCHEMBL30569129

NC1=Nc2ccsc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417108 0.71 BACE1 (0.51)
SCHEMBL7420414 0.71 CYP1A2 (0.56)
SCHEMBL7420397 0.69 NOS2 (0.49)
SCHEMBL7381137 0.68 NOS2 (0.36)
SCHEMBL7412405 0.67 NOS2 (0.35)
SCHEMBL7375377 0.67 NOS2 (0.42)
SCHEMBL7599428 0.66 NOS2 (0.41)
SCHEMBL3715393 0.64 CES1 (0.39)
SCHEMBL7135863 0.60 CES1 (0.36)
SCHEMBL8057615 0.58 NOS2 (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119212730-A Immunoconjugates comprising anti-CEA antibodies linked by conjugation to one or more 8-Het-2-aminobenzazepine derivatives for the treatment of cancer 博尔特生物治疗药物有限公司 2024-12-27 CN claimed
CN-116744978-A anti-HER 2 immunoconjugates and uses thereof 博尔特生物治疗药物有限公司 2023-09-12 CN claimed